Clinical studies with etoposide phosphate.

@article{Greco1996ClinicalSW,
  title={Clinical studies with etoposide phosphate.},
  author={Frank Anthony Greco and John D Hainsworth},
  journal={Seminars in oncology},
  year={1996},
  volume={23 6 Suppl 13},
  pages={45-50}
}
Over the past few years we have conducted several clinical studies with etoposide phosphate (Etopophos; Bristol-Myers Squibb Company, Princeton, NJ). A phase I trial initially was performed to determine the maximum tolerated dose and pharmacokinetics. A brief intravenous infusion for 5 consecutive days was given every 3 weeks. Myelosuppression was the dose… CONTINUE READING